Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Aratana Therapeutics, Inc. Announces Termination of Offering of Common Stock

Aratana Therapeutics,Inc.
Posted on: 29 Nov 17
Aratana Therapeutics, Inc. Announces Termination of Offering of Common Stock

PR Newswire

LEAWOOD, Kan., Nov. 28, 2017

LEAWOOD, Kan., Nov. 28, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats, today announced that it has terminated the offering of shares of its common stock that was announced on Monday, November 27, 2017. The company believes that current market conditions are not conducive for an offering on terms that would be in the best interests of its stockholders.

Contacts 
For investor inquires:
Craig Tooman
ctooman@aratana.com  
(913) 353-1026

For media inquiries: 
Rachel Reiff
rreiff@aratana.com  
(913) 353-1050

 

View original content with multimedia:http://www.prnewswire.com/news-releases/aratana-therapeutics-inc-announces-termination-of-offering-of-common-stock-300563255.html

SOURCE Aratana Therapeutics, Inc.

PR Newswire
www.prnewswire.com

Last updated on: 29/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.